Secondary hyperlipoproteinaemia type 3 (Q102536): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
 
(One intermediate revision by the same user not shown)
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
15 August 2026
Timestamp+2026-08-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 15 August 2026 / rank
 
Normal rank

Latest revision as of 19:35, 16 August 2026

This is the secondary form and involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL.
Language Label Description Also known as
default for all languages
ID_887392477
    English
    Secondary hyperlipoproteinaemia type 3
    This is the secondary form and involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL.

      Statements

      CID11:ID_887392477
      0 references
      dki-india-ID_887392477
      0 references
      Concluído
      0 references
      15 August 2026
      0 references